Azacitidine (intrathecal)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Azacitidine (intrathecal), covering 2025-06-26 to 2025-06-26. Get the full timeline:
Most recent: Clinical Trial Update: Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma [Phase 1]